Sorrento Therapeutics Inc.

08/04/2021 | Press release | Distributed by Public on 08/04/2021 11:00

Sorrento Announces Promising Results in a Publication Detailing of Salicyn-30 and Other Salicylanilides in Reducing SARS-CoV‑2 Replication and Suppressing Induction of[...]